A researcher at IRBLleida won the Young Investigators Awards for his research on the impact of sleep apnea on heart disease

The initiative of the AstraZeneca Foundation, in collaboration with the Instituto de Salud Carlos III, promotes innovative research and promoting scientific potential of young researchers.

Lleida, September 16th, 2016 Manuel Sánchez de la Torre, Group Translational Research in Respiratory Medicine at the Institute of Biomedical Research Foundation Dr. Lleida Pifarré (IRBLleida), led by Ferran Barbé, is one of four winners of the Second Young Researchers Awards delivers AstraZeneca Foundation, in collaboration with the Instituto de Salud Carlos II. An initiative that seeks to encourage innovative and promising research involving a substantial improvement in the lives of patients, and in turn contribute to enhance the talent of young researchers. Specifically, Sanchez de la Torre has been awarded € 20,000 for his research on "The impact of the apnea-hypopnea syndrome sleep in the evolution of acute coronary syndrome. Effect of intervention with continuous positive pressure (CPAP). " This funding will enable further research in this area. Research award aims to evaluate the impact of treatment of sleep apnea in the evolution of patients who have suffered an episode of acute coronary syndrome. In addition, the Group Translational Research in Respiratory Medicine focuses much of his research in the development of personalized medicine in sleep apnea, characterizing various phenotypes of the disease and the identification of tools genetic ability to predict a patient's clinical response to treatment. In 2016, a total of 90 researchers presented their project to get the scholarship in four therapeutic areas (type II diabetes and obesity, oncology, chronic obstructive pulmonary disease and acute coronary cardiac rehabilitation postsíndrome [SCA]); 25% of researchers in the first edition of the contest. For the general director of the Foundation AstraZeneca, Cecilia Taieb, "the increase in applications is a sign that in Spain we have an exceptional scientific talent." The cardiologist and director of the National Center for Cardiovascular Research (CNIC), Valentin Fuster, has was responsible for opening the award ceremony.